Cargando…

Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells

OBJECTIVE: Although T-cell immunoglobulin and mucin-domain containing molecule-3 (Tim-3) has been recognized as a promising target for cancer immunotherapy, its exact role in breast cancer has not been fully elucidated. METHODS: Tim-3 gene expression in breast cancer and its prognostic significance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cong, Yizi, Cui, Yuxin, Zhu, Shiguang, Cao, Jianqiao, Zou, Haidong, Martin, Tracey A., Qiao, Guangdong, Jiang, Wenguo, Yu, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666787/ https://www.ncbi.nlm.nih.gov/pubmed/33223752 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.05.02

Ejemplares similares

Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells
por: Cong, Yizi, et al.
Publicado: (2020)

Fascia Suture Technique Is a Simple Approach to Reduce Postmastectomy Seroma Formation
por: Cong, Yizi, et al.
Publicado: (2020)

Lipid-rich carcinoma of the breast: A report of two cases and a literature review
por: CONG, YIZI, et al.
Publicado: (2015)

Invasive cribriform carcinoma of the breast: A report of nine cases and a review of the literature
por: CONG, YIZI, et al.
Publicado: (2015)

Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer
por: Cong, Yizi, et al.
Publicado: (2020)

The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy
por: Cong, Yizi, et al.
Publicado: (2021)

Identification and verification of immune-related gene prognostic signature based on ssGSEA for breast cancer
por: Chen, Gang, et al.
Publicado: (2022)

NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
por: McFarland, Braden C., et al.
Publicado: (2013)

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways
por: Liu, Zhaoyun, et al.
Publicado: (2020)

STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
por: Li, Rui, et al.
Publicado: (2017)

Construction and analysis of a survival-associated competing endogenous RNA network in breast cancer
por: Chen, Gang, et al.
Publicado: (2023)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023)

Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity
por: Dou, Shuaijie, et al.
Publicado: (2021)

Correction: Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023)

Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis
por: Chen, Gang, et al.
Publicado: (2021)

Integrated transcriptome and network analysis identifies EZH2/CCNB1/PPARG as prognostic factors in breast cancer
por: Li, Yalun, et al.
Publicado: (2023)

Upregulated Tim-3/galectin-9 expressions in acute lung injury in a murine malarial model
por: Liu, Jinfeng, et al.
Publicado: (2015)

Ex vivo-expanded human CD19(+)TIM-1(+) regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
por: Shankar, S., et al.
Publicado: (2022)

STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer
por: Zhao, Jinlin, et al.
Publicado: (2021)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Zhang, Tingting, et al.
Publicado: (2020)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Dysregulated T cell expression of TIM3 in multiple sclerosis
por: Koguchi, Ken, et al.
Publicado: (2006)

Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Zhang, Tingting, et al.
Publicado: (2021)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
por: Souissi, Inès, et al.
Publicado: (2011)

TIM-3 and TIM-1 Could Regulate Decidual γδTCR Bright T Cells during Murine Pregnancy
por: Nörenberg, Jasper, et al.
Publicado: (2019)

TIM-3 increases the abundance of type-2 dendritic cells during Leishmania donovani infection by enhancing IL-10 production via STAT3
por: Mishra, Manish, et al.
Publicado: (2023)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

The effects of Tim-3 activation on T-cells in gastric cancer progression
por: Yu, Jiangtao, et al.
Publicado: (2019)

Association of TIM-3 expression with glucose metabolism in Jurkat T cells
por: Lee, Mi Jin, et al.
Publicado: (2020)

Tim-3 mediates T cell trogocytosis to limit antitumor immunity
por: Pagliano, Ornella, et al.
Publicado: (2022)

Cancer cell intrinsic TIM-3 induces glioblastoma progression
por: Guo, Qing, et al.
Publicado: (2022)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2016)

SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-κB Signaling Pathway
por: Xie, Yuankang, et al.
Publicado: (2023)

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
por: Sakuishi, Kaori, et al.
Publicado: (2013)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlb9imcfn1meelpq4tn63qj25t